In this paper we shall discuss some of the drivers behind the increasing number of pharmaceutical and biotechnology companies moving from traditional proprietary chemical information systems into modern alternatives. We shall explore the business drivers for change and discuss some of the issues which must be considered before migrating chemical information, including an analysis of common issues.
New approaches such as systems biology and translational medicine demand interoperability and integration of data and systems. Oracle data cartridge technology offers the opportunity to break the dependency between a pharmaceutical company's data and the software that manages it, encouraging an increase in the utilisation and value of data.
We shall discuss the benefits of this approach and explore how to achieve migration, focusing on the benefits of JChem Cartridge and the ChemAxon products.
Click here to view full paper (PDF)